Laurel Wealth Advisors Inc. Has $277,000 Stake in Colgate-Palmolive Company (CL)

Laurel Wealth Advisors Inc. held its position in shares of Colgate-Palmolive Company (NYSE:CL) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,732 shares of the company’s stock at the end of the third quarter. Laurel Wealth Advisors Inc.’s holdings in Colgate-Palmolive Company were worth $277,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Quadrant Capital Group LLC raised its position in shares of Colgate-Palmolive Company by 200.6% in the third quarter. Quadrant Capital Group LLC now owns 1,485 shares of the company’s stock worth $103,000 after buying an additional 991 shares during the last quarter. Bruderman Asset Management LLC raised its position in Colgate-Palmolive Company by 0.3% in the third quarter. Bruderman Asset Management LLC now owns 1,556 shares of the company’s stock valued at $115,000 after buying an additional 4 shares in the last quarter. Concannon Wealth Management LLC raised its position in Colgate-Palmolive Company by 33.8% in the third quarter. Concannon Wealth Management LLC now owns 1,605 shares of the company’s stock valued at $119,000 after buying an additional 405 shares in the last quarter. FCM Investments TX raised its position in Colgate-Palmolive Company by 38.9% in the third quarter. FCM Investments TX now owns 2,500 shares of the company’s stock valued at $185,000 after buying an additional 700 shares in the last quarter. Finally, Newman Dignan & Sheerar Inc. bought a new position in Colgate-Palmolive Company during the third quarter valued at approximately $193,000. Institutional investors own 73.00% of the company’s stock.

Institutional Ownership by Quarter for Colgate-Palmolive Company (NYSE:CL)

Shares of Colgate-Palmolive Company (NYSE:CL) traded up 1.68% during trading on Friday, hitting $67.72. The stock had a trading volume of 5,568,145 shares. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $75.38. The stock’s 50-day moving average price is $66.35 and its 200-day moving average price is $69.97. The company has a market cap of $60.12 billion, a P/E ratio of 24.90 and a beta of 0.70.

Colgate-Palmolive Company (NYSE:CL) last released its earnings results on Friday, January 27th. The company reported $0.75 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive Company had a return on equity of 4,897.09% and a net margin of 16.06%. The firm had revenue of $3.72 billion for the quarter, compared to the consensus estimate of $3.87 billion. During the same period in the prior year, the business posted $0.73 earnings per share. The firm’s revenue for the quarter was down 4.6% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive Company will post $2.91 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 15th. Investors of record on Monday, January 23rd will be given a dividend of $0.39 per share. The ex-dividend date is Thursday, January 19th. This represents a $1.56 annualized dividend and a yield of 2.30%. Colgate-Palmolive Company’s dividend payout ratio (DPR) is presently 57.35%.

TRADEMARK VIOLATION NOTICE: This article was originally posted by sleekmoney and is the property of of sleekmoney. If you are reading this article on another website, it was copied illegally and republished in violation of United States & international trademark and copyright legislation. The correct version of this article can be accessed at http://sleekmoney.com/laurel-wealth-advisors-inc-has-277000-stake-in-colgate-palmolive-company-cl/1656990.html.

Several research analysts have recently commented on the company. B. Riley reiterated a “neutral” rating and set a $74.00 price target on shares of Colgate-Palmolive Company in a report on Friday, February 3rd. Citigroup Inc. lowered Colgate-Palmolive Company from a “buy” rating to a “neutral” rating and set a $70.00 price target on the stock. in a report on Monday, January 30th. RBC Capital Markets set a $71.00 price target on Colgate-Palmolive Company and gave the stock a “hold” rating in a report on Monday, January 2nd. Barclays PLC reiterated a “hold” rating and set a $63.00 price target on shares of Colgate-Palmolive Company in a report on Tuesday, January 10th. Finally, Zacks Investment Research lowered Colgate-Palmolive Company from a “hold” rating to a “sell” rating in a report on Tuesday, December 27th. One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the stock. Colgate-Palmolive Company has an average rating of “Hold” and a consensus target price of $73.42.

In other news, insider Jennifer Daniels sold 7,072 shares of the firm’s stock in a transaction dated Tuesday, December 13th. The stock was sold at an average price of $66.78, for a total value of $472,268.16. Following the transaction, the insider now directly owns 37,463 shares in the company, valued at approximately $2,501,779.14. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Stephen I. Sadove sold 8,000 shares of the firm’s stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $66.00, for a total value of $528,000.00. Following the completion of the transaction, the director now owns 33,761 shares in the company, valued at $2,228,226. The disclosure for this sale can be found here. Insiders have sold 23,607 shares of company stock worth $1,562,774 over the last quarter. 1.05% of the stock is currently owned by company insiders.

About Colgate-Palmolive Company

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/laurel-wealth-advisors-inc-has-277000-stake-in-colgate-palmolive-company-cl/1656990.html

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *